Who are PiroGon's investors?

PiroGon's investors include Connecticut Innovations.

How much funding has PiroGon raised?

PiroGon has disclosed $1.3M raised across 1 round.

Where is PiroGon headquartered?

PiroGon is headquartered in North Haven, US.

PiroGon

North Haven, US · Founded 2021 · Delaware corporation · 1 known investors

Find your way into PiroGon

Paths you didn't know you had: your email and LinkedIn already hold routes to the PiroGon team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PiroGon is developing a closed-loop medical platform, based on technology from Yale University, that detects the backflow and spillover of stomach acid and dynamically restores airway protection to prevent aspiration pneumonia. It targets patients at risk of aspiration across neurologic, surgical, and critical-care settings.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Pramod BondeNamed on SEC filing

Rigu GuptaNamed on SEC filing

Investors · 1

Connecticut InnovationsreportedNew Haven · $500K – $2M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 1 round · 2022

▶$1.3MraisedMar 2024 · 25 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Pramod BondeDirector
Rigu GuptaExecutive Officer, Director

Offering amount: $1.3M
Amount sold: $1.3M
Minimum investment: $25K
First sale: Jan 2022
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does PiroGon do?: PiroGon is developing a closed-loop medical platform, based on technology from Yale University, that detects the backflow and spillover of stomach acid and dynamically restores airway protection to prevent aspiration pneumonia. It targets patients at risk of aspiration across neurologic, surgical, and critical-care settings.
Who are PiroGon's investors?: PiroGon's investors include Connecticut Innovations.
How much funding has PiroGon raised?: PiroGon has disclosed $1.3M raised across 1 round.
Where is PiroGon headquartered?: PiroGon is headquartered in North Haven, US.